Monoclonal Antibodies in Treating Food Allergy: A New Therapeutic Horizon

Food allergy (FA) is a pathological immune response, potentially deadly, induced by exposure to an innocuous and specific food allergen. To date, there is no specific treatment for FAs; thus, dietary avoidance and symptomatic medications represent the standard treatment for managing them. Recently, several therapeutic strategies for FAs, such as sublingual and epicutaneous immunotherapy and monoclonal antibodies, have shown long-term safety and benefits in clinical practice. This review summarizes the current evidence on changes in treating FA, focusing on monoclonal antibodies, which have recently provided encouraging data as therapeutic weapons modifying the disease course.

Automated summary

Food allergy is a pathological immune response triggered by exposure to specific food allergens, with no specific treatment available yet. Dietary avoidance and symptomatic medications are the main treatment methods currently employed. Recent therapeutic strategies like monoclonal antibodies have shown long-term safety and benefits in clinical practice.